GSK Investigational Site
Karachi 75950
0 studies enrolling now · 10 studies all time
What they study most
Alzheimer's Disease, Atherosclerosis, Chemotherapy-Induced Nausea and Vomiting, Diabetes Mellitus, Type 2, Nausea and Vomiting, Chemotherapy-Induced, Nausea and Vomiting, Postoperative, Neoplasms, Breast, Purpura, Thrombocytopaenic, Idiopathic
Studies at this site
- The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial — Completed
- Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease — Completed
- LENS - Long-term Eltrombopag Observational Study — Completed
- Lapatinib In Chemotherapy-Naive Or Metastatic Breast Cancer — Completed
- A Type 2 Diabetes Study of the Longer-Term Glycemic Effect of AVANDAMET vs. Metformin — Completed
- Casopitant (Oral) And ZOFRAN To Prevent Postoperative Nausea And Vomiting In Women — Completed
- SB-480848 In Subjects With Coronary Heart Disease — Completed
- Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Advanced Or Metastatic Breast Cancer — Completed
- Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy — Completed
- A Longitudinal 2-year Bone Marrow Study of Eltrombopag in Previously Treated Adults, With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) — Completed